EcoDrugPlus

Serine/threonine-Protein Kinase Chk2-Like

Ensembl ID : ENSSTUG00000011705
Gene Symbol: LOC115199789
3 Cross references
198 Possible Orthologues:

Serine/threonine-Protein Kinase Pak 4-Like

Ensembl ID : ENSSTUG00000021331
Gene Symbol: LOC115163187
3 Cross references
166 Possible Orthologues:

Serine/threonine-Protein Kinase Plk4-Like

Ensembl ID : ENSSTUG00000004138
Gene Symbol: LOC115162262
3 Cross references
208 Possible Orthologues:

Serine/threonine-Protein Kinase Plk4-Like

Ensembl ID : ENSSTUG00000013384
Gene Symbol: LOC115172555
3 Cross references
209 Possible Orthologues:

Serine/threonine-Protein Kinase Pim-1-Like

Ensembl ID : ENSSTUG00000050128
Gene Symbol: LOC115168587
3 Cross references
239 Possible Orthologues:

Serine/threonine-Protein Kinase Pim-1-Like

Ensembl ID : ENSSTUG00000046972
Gene Symbol: LOC115165948
3 Cross references
240 Possible Orthologues:

Serine/threonine-Protein Kinase Pim-3-Like

Ensembl ID : ENSSTUG00000018104
Gene Symbol: LOC115192750
3 Cross references
152 Possible Orthologues:

Serum Amyloid P-Component-Like

Ensembl ID : ENSSTUG00000013848
Gene Symbol: LOC115153088
2 Cross references
353 Possible Orthologues:

Si:dkey-211g8.6

Ensembl ID : ENSSTUG00000050114
Gene Symbol: SI:DKEY-211G8.6
1 Cross references
320 Possible Orthologues:

Sigma Non-Opioid Intracellular Receptor 1

Ensembl ID : ENSSTUG00000034185
Gene Symbol: SIGMAR1
3 Cross references
205 Possible Orthologues:

Sirtuin 1

Ensembl ID : ENSSTUG00000017950
Gene Symbol: SIRT1
3 Cross references
151 Possible Orthologues:

Smoothened Homolog

Ensembl ID : ENSSTUG00000041959
Gene Symbol: LOC115199140
3 Cross references
201 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).